Contributions of rare and common variation to early-onset and atypical dementia risk

We collected and analyzed genomic sequencing data from individuals with clinician diagnosed early-onset or atypical dementia. Thirty-two patients were previously described, with sixty-eight newly described in this report. Of those sixty-eight, sixty-two patients reported Caucasian, non-Hispanic ethnicity and six reported as African American, non-Hispanic. Fifty-three percent of patients had a returnable variant. Five patients harbored a pathogenic variant as defined by the American College of Medical Genetics criteria for pathogenicity. A polygenic risk score was calculated for Alzheimer's patients in the total cohort and compared to the scores of a late-onset Alzheimer's cohort and a control set. Patients with early-onset Alzheimer's had higher non-APOE polygenic risk scores than patients with late onset Alzheimer's, supporting the conclusion that both rare and common genetic variation associate with early-onset neurodegenerative disease risk.

[1]  P. Dupont,et al.  Association of Alzheimer’s disease polygenic risk scores with amyloid accumulation in cognitively intact older adults , 2022, Alzheimer's Research & Therapy.

[2]  C. Masters,et al.  Clinical impact of whole-genome sequencing in patients with early-onset dementia , 2022, Journal of Neurology, Neurosurgery, and Psychiatry.

[3]  B. Voight,et al.  Polygenic Risk Scores in Alzheimer’s Disease Genetics: Methodology, Applications, Inclusion, and Diversity , 2022, Journal of Alzheimer's disease : JAD.

[4]  J. Diehl-Schmid,et al.  The cerebrospinal fluid biomarker ratio Aβ42/40 identifies amyloid positron emission tomography positivity better than Aβ42 alone in a heterogeneous memory clinic cohort , 2022, Alzheimer's Research & Therapy.

[5]  W. M. van der Flier,et al.  Exome sequencing identifies rare damaging variants in the ATB8B4 and ABCA1 genes as novel risk factors for Alzheimer’s disease , 2021, Alzheimer's & dementia : the journal of the Alzheimer's Association.

[6]  K. Lunetta,et al.  Novel Alzheimer Disease Risk Loci and Pathways in African American Individuals Using the African Genome Resources Panel: A Meta-analysis. , 2020, JAMA neurology.

[7]  K. Xia,et al.  Identification of Alzheimer's disease-associated rare coding variants in the ECE2 gene. , 2020, JCI insight.

[8]  A. Goate,et al.  Systematic validation of variants of unknown significance in APP, PSEN1 and PSEN2 , 2020, Neurobiology of Disease.

[9]  T. Prior,et al.  A case report of genetic prion disease with two different PRNP variants , 2020, Molecular genetics & genomic medicine.

[10]  Ryan L. Collins,et al.  The mutational constraint spectrum quantified from variation in 141,456 humans , 2020, Nature.

[11]  M. Stoimenova-Popova,et al.  A Clinical Case of Patient Carrying Rare Pathological PSEN1 Gene Mutation (L424V) Demonstrates the Phenotypic Heterogenity of Early Onset Familial AD , 2019, Front. Psychiatry.

[12]  Brittany N. Lasseigne,et al.  Genome sequencing for early-onset or atypical dementia: high diagnostic yield and frequent observation of multiple contributory alleles , 2019, Cold Spring Harbor molecular case studies.

[13]  Mikel Hernaez,et al.  Sentieon DNASeq Variant Calling Workflow Demonstrates Strong Computational Performance and Accuracy , 2019, Front. Genet..

[14]  D. Campion,et al.  SORL1 genetic variants and Alzheimer disease risk: a literature review and meta-analysis of sequencing data , 2019, Acta Neuropathologica.

[15]  Konrad Scheffler,et al.  ExpansionHunter: a sequence-graph-based tool to analyze variation in short tandem repeat regions , 2019, bioRxiv.

[16]  Gabor T. Marth,et al.  VarSight: prioritizing clinically reported variants with binary classification algorithms , 2019, BMC Bioinformatics.

[17]  Zachariah M. Reagh,et al.  ABCA7 risk variant in healthy older African Americans is associated with a functionally isolated entorhinal cortex mediating deficient generalization of prior discrimination training , 2018, Hippocampus.

[18]  A. Fagan,et al.  Discovery and validation of autosomal dominant Alzheimer’s disease mutations , 2018, Alzheimer's Research & Therapy.

[19]  Christopher T. Saunders,et al.  Strelka2: fast and accurate calling of germline and somatic variants , 2018, Nature Methods.

[20]  D. Goldstein,et al.  Whole‐exome sequencing in 20,197 persons for rare variants in Alzheimer's disease , 2018, Annals of clinical and translational neurology.

[21]  A. Fagan,et al.  Polygenic risk score of sporadic late-onset Alzheimer's disease reveals a shared architecture with the familial and early-onset forms , 2018, Alzheimer's & Dementia.

[22]  Shekhar Saxena,et al.  WORLD HEALTH ORGANIZATION’S GLOBAL ACTION PLAN ON THE PUBLIC HEALTH RESPONSE TO DEMENTIA 2017-2025 , 2017, Alzheimer's & Dementia.

[23]  W. M. van der Flier,et al.  Characterization of pathogenic SORL1 genetic variants for association with Alzheimer’s disease: a clinical interpretation strategy , 2017, European Journal of Human Genetics.

[24]  Jae-Hwan Jhong,et al.  Erratum to: Meta-analytic support vector machine for integrating multiple omics data , 2017, BioData Min..

[25]  R. J. Kelleher,et al.  Presenilin-1 mutations and Alzheimer’s disease , 2017, Proceedings of the National Academy of Sciences.

[26]  Chris Shaw,et al.  Detection of long repeat expansions from PCR-free whole-genome sequence data , 2016, bioRxiv.

[27]  R. Myers,et al.  Genomic diagnosis for children with intellectual disability and/or developmental delay , 2016, bioRxiv.

[28]  P. Park,et al.  Copy number analysis of whole-genome data using BIC-seq2 and its application to detection of cancer susceptibility variants , 2016, Nucleic acids research.

[29]  Nizamettin Aydin,et al.  Splice sites prediction of human genome using AdaBoost , 2016, 2016 IEEE-EMBS International Conference on Biomedical and Health Informatics (BHI).

[30]  H. Gurvit,et al.  Adult-onset phenylketonuria with rapidly progressive dementia and parkinsonism , 2016, Neurocase.

[31]  James Y. Zou.  Analysis of protein-coding genetic variation in 60,706 humans , 2015, Nature.

[32]  Yongwook Choi,et al.  PROVEAN web server: a tool to predict the functional effect of amino acid substitutions and indels , 2015, Bioinform..

[33]  Bale,et al.  Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology , 2015, Genetics in Medicine.

[34]  Eric Boerwinkle,et al.  In silico prediction of splice-altering single nucleotide variants in the human genome , 2014, Nucleic acids research.

[35]  A. Federico,et al.  Adult-onset phenylketonuria revealed by acute reversible dementia, prosopagnosia and parkinsonism , 2014, Journal of Neurology.

[36]  A. George,et al.  Novel SCN5A mutation in amiodarone-responsive multifocal ventricular ectopy-associated cardiomyopathy. , 2014, Heart rhythm.

[37]  J. Shendure,et al.  A general framework for estimating the relative pathogenicity of human genetic variants , 2014, Nature Genetics.

[38]  Nick C Fox,et al.  Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease , 2013, Nature Genetics.

[39]  David A. Bennett,et al.  The PSEN1, p.E318G Variant Increases the Risk of Alzheimer's Disease in APOE-ε4 Carriers , 2013, PLoS genetics.

[40]  Oscar L Lopez,et al.  Variants in the ATP-binding cassette transporter (ABCA7), apolipoprotein E ϵ4,and the risk of late-onset Alzheimer disease in African Americans. , 2013, JAMA.

[41]  Heng Li.  Aligning sequence reads, clone sequences and assembly contigs with BWA-MEM , 2013, 1303.3997.

[42]  K. Shianna,et al.  Using ERDS to infer copy-number variants in high-coverage genomes. , 2012, American journal of human genetics.

[43]  Thomas Zichner,et al.  DELLY: structural variant discovery by integrated paired-end and split-read analysis , 2012, Bioinform..

[44]  Marc Cruts,et al.  Locus-Specific Mutation Databases for Neurodegenerative Brain Diseases , 2012, Human mutation.

[45]  Jennifer Williamson,et al.  Rare Variants in APP, PSEN1 and PSEN2 Increase Risk for AD in Late-Onset Alzheimer's Disease Families , 2012, PloS one.

[46]  Gonçalo R. Abecasis,et al.  The variant call format and VCFtools , 2011, Bioinform..

[47]  M. Gerstein,et al.  CNVnator: an approach to discover, genotype, and characterize typical and atypical CNVs from family and population genome sequencing. , 2011, Genome research.

[48]  Josyf Mychaleckyj,et al.  Robust relationship inference in genome-wide association studies , 2010, Bioinform..

[49]  P. Bork,et al.  A method and server for predicting damaging missense mutations , 2010, Nature Methods.

[50]  J. Towbin,et al.  An international compendium of mutations in the SCN5A-encoded cardiac sodium channel in patients referred for Brugada syndrome genetic testing. , 2010, Heart rhythm.

[51]  Hadley Wickham,et al.  ggplot2 - Elegant Graphics for Data Analysis (2nd Edition) , 2017 .

[52]  J. Morris,et al.  Molecular characterization of novel progranulin (GRN) mutations in frontotemporal dementia , 2008, Human mutation.

[53]  C. Haass,et al.  Missense Mutations in the Progranulin Gene Linked to Frontotemporal Lobar Degeneration with Ubiquitin-immunoreactive Inclusions Reduce Progranulin Production and Secretion* , 2008, Journal of Biological Chemistry.

[54]  J. Neuhaus,et al.  Comparison of family histories in FTLD subtypes and related tauopathies , 2005, Neurology.

[55]  A. Goate,et al.  Tau (MAPT) mutation Arg406Trp presenting clinically with Alzheimer disease does not share a common founder in Western Europe , 2003, Human mutation.

[56]  Steven Henikoff,et al.  SIFT: predicting amino acid changes that affect protein function , 2003, Nucleic Acids Res..

[57]  J. Haines,et al.  Effects of Age, Sex, and Ethnicity on the Association Between Apolipoprotein E Genotype and Alzheimer Disease: A Meta-analysis , 1997 .

[58]  M. L. Schmidt,et al.  Autosomal dominant dementia with widespread neurofibrillary tangles , 1997, Annals of neurology.